Barclays »

Kalvista Pharmaceuticals shares owned by Barclays

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $521k 43k 12.25
2023-09-30 $40k 4.2k 9.49
2023-06-30 $44k 4.9k 8.97
2023-03-31 $97k 12k 7.84
2022-12-31 $45k 6.6k 6.85
2022-09-30 $38k 2.6k 14.45
2022-06-30 $19k 2.0k 9.77
2022-03-31 $54k 3.6k 14.84
2021-12-31 $383k 29k 13.21
2021-09-30 $181k 10k 17.39
2021-06-30 $123k 5.1k 24.17
2021-03-31 $855k 33k 25.69
2020-12-31 $261k 14k 19.10
2020-09-30 $184k 15k 12.58
2020-06-30 $169k 14k 12.10
2020-03-31 $81k 11k 7.62
2019-12-31 $444k 25k 17.83
2019-09-30 $210k 18k 11.64
2019-06-30 $511k 23k 22.20
2019-03-31 $930k 33k 28.63
2018-12-31 $1.2M 63k 19.75
2018-09-30 $2.0k 71 28.17
2017-12-31 $13k 1.3k 9.64